Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DExD-box helicase 21 (DDX21) is a multifunctional RNA helicase belonging to the DEAD-box (DExD-box) family, with a distinct Asp–Glu–Val–Asp motif. Mainly localized in the nucleolus, DDX21 is crucial for the processing and modification of ribosomal RNA, regulation of RNA polymerase I and II transcription, and maintenance of RNA structure, including resolving R loops and G-quadruplexes. It has ATPase and RNA foldase activities in addition to its core helicase activity. DDX21 regulates both cell proliferation and apoptosis, and is implicated in cancer biology and immune responses to viral infection. Abnormal DDX21 expression or regulation has been linked to tumorigenesis, DNA damage responses, and certain autoimmune diseases. Although not currently a common therapeutic drug target, its diverse functions and roles in cancer and antiviral responses make it a potential candidate for future interventions[1][2][3][4].
Inhibition or modulation of helicase activity; Regulation of post-translational modifications (e.g., acetylation/deacetylation affecting helicase function)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DExD-box helicase 21 (DDX21).